These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1018 related items for PubMed ID: 28050651

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. A Phase 2 Trial of Alternative Volumes of Oropharyngeal Irradiation for De-intensification (AVOID): Omission of the Resected Primary Tumor Bed After Transoral Robotic Surgery for Human Papilloma Virus-Related Squamous Cell Carcinoma of the Oropharynx.
    Swisher-McClure S, Lukens JN, Aggarwal C, Ahn P, Basu D, Bauml JM, Brody R, Chalian A, Cohen RB, Fotouhi-Ghiam A, Geiger G, Gershowitz J, Livolsi V, Mitra N, Montone K, Newman J, Ojerholm E, O'Malley B, Rajasekaran K, Tan E, Weinstein G, Lin A.
    Int J Radiat Oncol Biol Phys; 2020 Mar 15; 106(4):725-732. PubMed ID: 31785337
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Minimally invasive surgery versus radiotherapy/chemoradiotherapy for small-volume primary oropharyngeal carcinoma.
    Howard J, Masterson L, Dwivedi RC, Riffat F, Benson R, Jefferies S, Jani P, Tysome JR, Nutting C.
    Cochrane Database Syst Rev; 2016 Dec 11; 12(12):CD010963. PubMed ID: 27943254
    [Abstract] [Full Text] [Related]

  • 8. Oncological outcomes post transoral robotic surgery (TORS) for HPV-associated oropharyngeal squamous cell carcinoma, a single-centre retrospective Australian study.
    Kornfeld B, Taha A, Kyang L, Sim HW, Dewhurst S, McCloy R, Chin V, Earls P, Parker A, Leavers B, Forstner D, Floros P, Crawford J, Gallagher R.
    J Robot Surg; 2024 May 28; 18(1):226. PubMed ID: 38806847
    [Abstract] [Full Text] [Related]

  • 9. Patterns of cervical node positivity, regional failure rates, and fistula rates for HPV+ oropharyngeal squamous cell carcinoma treated with transoral robotic surgery (TORS).
    Cannon RB, Houlton JJ, Patel S, Raju S, Noble A, Futran ND, Parvathaneni U, Méndez E.
    Oral Oncol; 2018 Nov 28; 86():296-300. PubMed ID: 30409315
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Early-stage squamous cell carcinoma of the oropharynx: radiotherapy vs. trans-oral robotic surgery (ORATOR)--study protocol for a randomized phase II trial.
    Nichols AC, Yoo J, Hammond JA, Fung K, Winquist E, Read N, Venkatesan V, MacNeil SD, Ernst DS, Kuruvilla S, Chen J, Corsten M, Odell M, Eapen L, Theurer J, Doyle PC, Wehrli B, Kwan K, Palma DA.
    BMC Cancer; 2013 Mar 20; 13():133. PubMed ID: 23514246
    [Abstract] [Full Text] [Related]

  • 13. Outcomes in surgically resectable oropharynx cancer treated with transoral robotic surgery versus definitive chemoradiation.
    Dhanireddy B, Burnett NP, Sanampudi S, Wooten CE, Slezak J, Shelton B, Shelton L, Shearer A, Arnold S, Kudrimoti M, Gal TJ.
    Am J Otolaryngol; 2019 Mar 20; 40(5):673-677. PubMed ID: 31201038
    [Abstract] [Full Text] [Related]

  • 14. Oncological outcome following de-intensification of treatment for stage I and II HPV negative oropharyngeal cancers with transoral robotic surgery (TORS): A prospective trial.
    Dabas S, Gupta K, Ranjan R, Sharma AK, Shukla H, Dinesh A.
    Oral Oncol; 2017 Jun 20; 69():80-83. PubMed ID: 28559025
    [Abstract] [Full Text] [Related]

  • 15. The impact of transoral robotic surgery on the overall treatment of oropharyngeal cancer patients.
    Smith RV, Schiff BA, Garg M, Haigentz M.
    Laryngoscope; 2015 Nov 20; 125 Suppl 10():S1-S15. PubMed ID: 26436491
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Utility of up-front transoral robotic surgery in tailoring adjuvant therapy.
    Gildener-Leapman N, Kim J, Abberbock S, Choby GW, Mandal R, Duvvuri U, Ferris RL, Kim S.
    Head Neck; 2016 Aug 20; 38(8):1201-7. PubMed ID: 27225507
    [Abstract] [Full Text] [Related]

  • 19. Management of Recurrent and Metastatic HPV-Positive Oropharyngeal Squamous Cell Carcinoma after Transoral Robotic Surgery.
    Sims JR, Van Abel K, Martin EJ, Lohse CM, Price DL, Olsen KD, Moore EJ.
    Otolaryngol Head Neck Surg; 2017 Jul 20; 157(1):69-76. PubMed ID: 28374634
    [Abstract] [Full Text] [Related]

  • 20. Risk of Pathologic Extranodal Extension and Other Adverse Features After Transoral Robotic Surgery in Patients With HPV-Positive Oropharynx Cancer.
    Zebolsky AL, George E, Gulati A, Wai KC, Carpenter P, Van Zante A, Ha PK, Heaton CM, Ryan WR.
    JAMA Otolaryngol Head Neck Surg; 2021 Dec 01; 147(12):1080-1088. PubMed ID: 34673904
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 51.